A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources?human, animal, plant, fungal, or microbial.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceuticals. This report contains market size and forecasts of Biopharmaceuticals in global, including the following market information:
- Global Biopharmaceuticals Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Biopharmaceuticals market was valued at US$ 33340 million in 2022 and is projected to reach US$ 55870 million by 2029, at a CAGR of 7.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biopharmaceuticals include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biopharmaceuticals companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biopharmaceuticals Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Biopharmaceuticals Market Segment Percentages, by Type, 2022 (%)
- Monoclonal Antibodies
- Interferon
- Colony-Stimulating Factor
- Erythropoietin
- Insulin
- Vaccines
- Growth Hormones
- Others
Global Biopharmaceuticals Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Biopharmaceuticals Market Segment Percentages, by Application, 2022 (%)
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Others
Global Biopharmaceuticals Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Biopharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biopharmaceuticals revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Biopharmaceuticals revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche
- Amgen
- AbbVie
- Sanofi-Aventis
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
- Sun
- 3sbio
- Changchun High Tech
- CP Guojian
- Biotech
- Gelgen
- Innovent
- Dong Bao
- Ganlee
- United Laboratories
- SANDOZ (NOVARTIS)
- Teva Pharmaceutical
- Hospira ?Pfizer?
- MYLAN
- Sun pharma
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Biopharmaceuticals, market overview.
- Chapter 2: Global Biopharmaceuticals market size in revenue.
- Chapter 3: Detailed analysis of Biopharmaceuticals company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Biopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
